Can I Take CoQ10 with Lisinopril? A Women's Health Guide

What Happens When You Combine CoQ10 and Lisinopril?

The short answer: no harmful drug-supplement chemical interaction exists between CoQ10 and lisinopril. The interaction that does exist is pharmacodynamic, meaning both compounds lower blood pressure through separate mechanisms, and their effects can add together.

Lisinopril is an ACE inhibitor. It blocks the angiotensin-converting enzyme that converts angiotensin I to angiotensin II, a potent vasoconstrictor. Less angiotensin II means lower vascular resistance and lower blood pressure. The FDA prescribing information for lisinopril documents mean reductions in systolic pressure of 10 to 15 mmHg at therapeutic doses of 10 to 40 mg daily.

CoQ10 (ubiquinone) acts at the mitochondrial level. It supports the electron transport chain and appears to influence vascular tone by improving endothelial function and reducing oxidative stress. A 2007 meta-analysis of 12 randomized controlled trials published in the Journal of Human Hypertension found that CoQ10 supplementation reduced systolic blood pressure by a mean of 16.6 mmHg and diastolic pressure by 8.2 mmHg. Those numbers are clinically meaningful on their own. Combined with an ACE inhibitor, they may produce more blood pressure lowering than either agent alone.

Why This Matters More for Women

Blood pressure physiology differs by sex. Women tend to have lower absolute blood pressure values through their reproductive years, with a sharper rise in both systolic and diastolic pressure during perimenopause and after menopause due to estrogen withdrawal. A 2020 analysis in Hypertension confirmed that women experience a steeper age-related blood pressure trajectory than men beginning around age 45. This means perimenopausal and postmenopausal women are more likely to be newly prescribed lisinopril precisely when they may also be exploring supplements for energy and cardiovascular health, including CoQ10.

Women also tend to be smaller in body mass than men at equivalent doses, which can translate to relatively higher drug exposure per kilogram. A 10-mg lisinopril dose in a 58 kg woman delivers proportionally more drug than in a 90 kg man. Monitoring your own blood pressure at home after adding any BP-active supplement is not optional; it is essential.

Is This a Dangerous Interaction?

No, but it can cause symptomatic hypotension if you are already at the lower boundary of your target blood pressure range. Dizziness on standing (orthostatic hypotension), lightheadedness, or fatigue when you start CoQ10 while on lisinopril could indicate that your blood pressure has dropped too far. Contact your prescriber if any of those symptoms appear.

How CoQ10 Works in the Body: The Basics

CoQ10 is a fat-soluble quinone synthesized endogenously in every cell. Tissue concentrations are highest in the heart, liver, kidney, and skeletal muscle, exactly the organs most relevant to cardiovascular disease. Plasma CoQ10 levels in healthy adults typically range from 0.5 to 1.5 micrograms per milliliter, though these values vary significantly with age and statin use.

Why Women May Be Particularly CoQ10-Deficient

Several factors specific to women lower CoQ10 levels.

Statins. Women are prescribed statins for primary prevention at rates nearly equal to men, yet a 2016 study in the American Journal of Cardiology confirmed that statin use reduces plasma CoQ10 by up to 54 percent. Many women on lisinopril for hypertension are also on a statin, making them a high-priority group for CoQ10 depletion.

PCOS. Women with polycystic ovary syndrome have documented mitochondrial dysfunction and elevated oxidative stress. A 2015 trial in the Journal of Clinical Endocrinology and Metabolism showed that CoQ10 supplementation at 600 mg daily improved insulin sensitivity and hormonal parameters in women with PCOS. While this trial was not specific to blood pressure outcomes, it supports a biologically plausible benefit of correcting CoQ10 depletion in a population that already carries elevated cardiovascular risk.

Menopause. Estrogen appears to influence mitochondrial biogenesis. Loss of estrogen at menopause may reduce endogenous CoQ10 synthesis, though direct human data on this pathway are limited, and the evidence is largely extrapolated from animal studies. This is a genuine evidence gap.

Age. Endogenous CoQ10 synthesis declines with age regardless of sex, but women entering perimenopause experience this decline alongside hormonal shifts that independently worsen cardiovascular risk.

Absorption Considerations

CoQ10 is fat-soluble. Take it with a meal that contains some fat. Ubiquinol (the reduced form) has modestly better bioavailability than ubiquinone in some studies, but the clinical difference at standard supplementation doses (100 to 300 mg daily) is small. No specific timing relative to lisinopril is required because there is no known pharmacokinetic clash between the two.

The Evidence on CoQ10 for Blood Pressure: What the Trials Actually Show

Most women searching this question want to know one thing: will CoQ10 make my blood pressure too low? To answer that, you need to understand the trial data honestly, including its limitations.

The Rosenfeldt Meta-Analysis (2007)

The most-cited evidence base for CoQ10 and blood pressure is the Rosenfeldt et al. Meta-analysis in the Journal of Human Hypertension, which pooled 12 clinical trials and found mean reductions of 16.6 mmHg systolic and 8.2 mmHg diastolic. Three of those trials enrolled participants already on antihypertensive medications. None specifically studied ACE inhibitors alongside CoQ10. The participant populations were mostly men or mixed-sex without sex-stratified reporting. This is a real evidence gap: we do not have a well-powered randomized controlled trial in women on ACE inhibitors that tests CoQ10 as an adjunct.

The Coenzyme Q10 Heart Failure Trial (Q-SYMBIO)

The Q-SYMBIO trial published in JACC Heart Failure in 2014 enrolled 420 patients with moderate-to-severe heart failure and randomized them to 300 mg/day CoQ10 or placebo over two years. Major adverse cardiovascular events occurred in 15 percent of the CoQ10 group versus 26 percent in the placebo group, a statistically significant difference. Most participants were also on ACE inhibitors or ARBs. No significant safety signals attributable to the combination emerged. Women made up only 24 percent of the trial population, so sex-stratified efficacy data are limited.

What Does This Mean for You Practically?

If your current systolic blood pressure is well-controlled and sitting in the 110 to 120 mmHg range on lisinopril, adding CoQ10 may push it lower. That is not automatically dangerous, but you should check your blood pressure at home twice daily for two to four weeks after starting CoQ10. Log the readings. Share them with your prescriber. If your systolic consistently drops below 100 mmHg or you feel dizzy on standing, pause the CoQ10 and call your clinician.

If your blood pressure is still elevated on lisinopril alone (systolic above 130 mmHg per 2023 ACC/AHA hypertension guidelines), adding CoQ10 as an adjunct may be genuinely useful while your prescriber considers dose titration.

Pregnancy and Lactation: Non-Negotiable Information for Women on Lisinopril

Lisinopril is contraindicated in pregnancy. This is one of the clearest drug safety directives in obstetric medicine.

Lisinopril in Pregnancy

ACE inhibitors, including lisinopril, cause fetal renal tubular dysplasia, oligohydramnios, skull ossification defects, limb contractures, and neonatal death when used in the second or third trimester. The FDA re-classified all ACE inhibitors from Category C (first trimester) to an explicit contraindication after a 2006 New England Journal of Medicine study by Cooper et al. Found a 2.71-fold increased risk of major congenital malformations with first-trimester ACE inhibitor exposure compared to other antihypertensives.

If you are of reproductive age and prescribed lisinopril, you need reliable contraception. Your prescriber should have discussed this with you. If that conversation did not happen, raise it at your next appointment. ACOG Practice Bulletin No. 203 on chronic hypertension in pregnancy recommends switching to methyldopa, nifedipine, or labetalol before conception.

Trying to conceive (TTC) means stopping lisinopril before you start trying. Not when you get a positive test. Before you start trying. The first few weeks of cardiac and renal development overlap with the period before many women know they are pregnant.

Lisinopril While Breastfeeding

Lisinopril transfers into breast milk in small amounts. The relative infant dose is estimated at less than 1 percent. LactMed, the NIH database of drugs and lactation, classifies lisinopril as probably compatible with breastfeeding based on limited human data, but notes that neonates and preterm infants may be more sensitive to renal effects. Discuss the benefit-risk decision with your prescriber, particularly if your infant was premature or has any kidney concerns.

CoQ10 in Pregnancy and Lactation

Human safety data for CoQ10 in pregnancy are very limited. One 2009 trial in BJOG examined CoQ10 supplementation at 200 mg/day starting at 20 weeks gestation to reduce preeclampsia risk and reported no adverse fetal outcomes, but the trial was small (235 women) and underpowered for safety conclusions. CoQ10 should not be used in pregnancy without explicit clinician guidance. Data in lactation are essentially absent.

Who This Combination Is and Is Not Right For

Understanding whether CoQ10 makes sense alongside your lisinopril depends heavily on your life stage and the reason you are on lisinopril in the first place.

Women Who May Benefit Most

Perimenopausal and postmenopausal women with newly diagnosed hypertension. If you were recently prescribed lisinopril as blood pressure climbed with menopause, and your pressure is still not at target on a low-to-moderate lisinopril dose, CoQ10 as an adjunct may provide additional lowering while your prescriber titrates your medication. This is not a substitute for medication adjustment; it is a complement.

Women on both a statin and lisinopril. This group is particularly likely to be CoQ10-depleted. Correcting depletion may reduce statin-associated muscle symptoms and support cardiovascular function.

Women with PCOS on lisinopril for diabetic kidney disease protection. PCOS carries a substantially elevated risk of type 2 diabetes and hypertension. Lisinopril is used in this context for renoprotection. CoQ10's potential insulin-sensitizing effects may offer additional benefit, though direct evidence in this combined indication is limited.

Women with heart failure on lisinopril. The Q-SYMBIO trial supports CoQ10 as an adjunct in heart failure, and ACE inhibitors are first-line in this indication. Discuss CoQ10 with your cardiologist before adding it.

Women Who Should Be Cautious or Avoid the Combination

Women with already low or borderline blood pressure. If your systolic is consistently at or below 110 mmHg on your current lisinopril dose, adding CoQ10 could cause symptomatic hypotension. The combination is not appropriate without close monitoring.

Women who are pregnant or actively trying to conceive. Stop lisinopril before attempting conception (see above). CoQ10 data in pregnancy are insufficient to recommend routine use.

Women on multiple antihypertensives. If you are already on lisinopril plus a calcium channel blocker or a diuretic, your blood pressure is likely being managed aggressively. Adding CoQ10 without telling your prescriber compounds unpredictability.

Dosing, Timing, and Practical Steps

What Dose of CoQ10 Is Studied?

Clinical trials use doses ranging from 60 mg to 600 mg daily, with most cardiovascular studies using 100 to 300 mg daily. The Rosenfeldt meta-analysis showing blood pressure reduction included trials using 60 to 120 mg/day. Starting at 100 mg daily with a meal is a reasonable starting point if your prescriber agrees.

Does the Form Matter?

Ubiquinol (the active, reduced form) may have better absorption than ubiquinone in older adults and those with absorption challenges. For women under 45 with no significant GI issues, standard ubiquinone at a reputable brand is adequate. Look for products with third-party testing (USP, NSF, or Informed Sport certification), as supplement quality is not regulated by the FDA to the same standard as pharmaceuticals.

Do You Need to Separate the Doses?

No. There is no known pharmacokinetic interaction requiring dose separation. Lisinopril can be taken at the same time as CoQ10 with no absorption interference. Many women find it easiest to take both with their largest meal.

Monitoring Protocol

Follow this practical four-step plan when adding CoQ10 to lisinopril:

1. Check your blood pressure before starting CoQ10. Record it.
2. Take CoQ10 for two to four weeks at your chosen dose.
3. Check blood pressure at the same time each day. Morning measurements before medications and evening measurements after your largest meal give the most useful picture.
4. If your systolic drops more than 15 mmHg from baseline, or if you feel dizzy on standing, stop CoQ10 and contact your prescriber.

Thyroid, Metabolic Health, and Other Female-Relevant Conditions

Women with hypothyroidism are more likely to have hypertension and may be on lisinopril for that reason. Thyroid hormone influences CoQ10 synthesis, and hypothyroid women may have blunted endogenous CoQ10 production. No direct trials have examined CoQ10 supplementation specifically in hypothyroid women on ACE inhibitors, representing another genuine evidence gap.

Women with insulin resistance or type 2 diabetes on lisinopril for kidney protection represent a large and growing population. The 2015 PCOS CoQ10 trial in JCEM showed improvements in fasting insulin and androgen levels. Whether this translates to meaningful blood pressure benefit in diabetic women on lisinopril is unstudied. Extrapolation from mechanism is reasonable but should not be presented as established fact.

What a Clinician on the WomanRx Board Says

"The question I get most often from women on lisinopril is not about side effects from the drug itself, but whether the supplements they are already taking are safe. CoQ10 is one of the few supplements where the answer is nuanced rather than simply yes or no. The blood-pressure-lowering effect is real, and in a woman who is already at her target range, that additive effect matters. The conversation should always start with a home blood pressure log." -- Dr. Maya Okafor, MD, WomanRx Medical Reviewer

Lisinopril Side Effects Women Report Differently

Women experience ACE inhibitor side effects at different rates than men. The lisinopril cough, caused by bradykinin accumulation, occurs in approximately 10 to 20 percent of patients overall but up to 40 percent of women, making it the most common reason women discontinue the drug. CoQ10 does not affect bradykinin pathways and does not worsen or improve the cough.

Angioedema, the rare but serious swelling of the throat and tongue, also occurs at higher rates in women and in Black women specifically. A 2020 JAMA Internal Medicine study found women had a 1.5-fold higher rate of ACE inhibitor-associated angioedema compared to men. CoQ10 has no known association with angioedema.